A recent study revealed that bevacizumab (Avastin) provides survival benefits in patients with colorectal cancer (CRC) for ...

The directors of the Irish arm of pharma giant Roche have stated that there is a need to reduce the lengthy timelines to ...

Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

HK inno.N will handle domestic marketing and sales of the targeted cancer drug "Avastin" from global pharmaceutical company Roche for colorectal and gynecological cancers. HK inno.N noted on the ...

Latest news on Ireland's companies and busines organisations and their impact locally, nationally and globally.

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

However, Amgen proactively launched its own biosimilars, such as Rayos and Pennsaid, to retain its market footprint in ...

Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...